EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson’s Disease: A Meta-Analysis

Dan Xie, Ling Feng, Hongyan Huang, Quanzhen Zhao, Pingping Ning, Qiuyan Shen, Haitao Lu, Fang Xu, Yanming Xu iD

Behavioural Neurology · 31.05.2021 · 2021 · 1-9

DOI: 10.1155/2021/5559383 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Behavioural Neurology, erschienen am 31.05.2021. Verfasst von Dan Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Sichuan University West China Hospital, Chengdu, 610041 Sichuan, China. Hauptthemen laut MEDLINE: Multiple System Atrophy, Parkinson Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Project of Sichuan Province, Department of Science and Technology of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the differences of candidate cerebrospinal fluid (CSF) biomarkers associated with multiple system atrophy (MSA) and Parkinson’s disease (PD).

Method

Here, a systematic review and meta-analysis were conducted on studies related to CSF biomarkers associated with MSA and PD obtained from PubMed, Web of Science, Embase, and Cochrane databases. Data were pooled where appropriate and used to calculate standardized mean differences (SMDs) with 95% confidence intervals (CI). Heterogeneity was assessed using the I 2 statistic while Egger’s test was used to test for existing publication bias.

Results

MSA patients had higher CSF t-tau ( SMD = 0.41 , 95% CI: 0.10 to 0.72) and YKL-40 ( SMD = 0.63 , 95% CI 0.12 to1.15) as well as DJ-1 ( SMD = 1.05 , 95% CI 0.67 to 1.42) levels than PD patients, while CSF p-tau ( SMD = − 0.17 , 95% CI, -0.31 to -0.02) and Aβ-42 ( SMD = − 0.33 , 95% CI, -0.55 to -0.12) levels in MSA patients were lower than those in PD patients. There were no differences in CSF’s GFAP and Flt3 ligand levels in both MSA and PD patients.

Conclusion

The study revealed the differences in CSF biomarker levels between MSA and PD cohorts that can be further explored to clinically distinguish MSA from PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple System AtrophyParkinson DiseaseBiomarkersDatabases, FactualHumans

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, Sichuan University West China Hospital, Chengdu, 610041 Sichuan, China.

ORCID-Profile: Yanming Xu

Förderung

  • Key Research and Development Project of Sichuan Province
  • Department of Science and Technology of Sichuan Province

Zitieren

APA

Xie, D., Feng, L., Huang, H., Zhao, Q., Ning, P., Shen, Q., Lu, H., Xu, F., & Xu, Y. (2021). Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson’s Disease: A Meta-Analysis. Behavioural Neurology, 2021, 1-9. https://doi.org/10.1155/2021/5559383

Vancouver

Xie D, Feng L, Huang H, Zhao Q, Ning P, Shen Q, et al. Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson’s Disease: A Meta-Analysis. Behavioural Neurology. 2021;2021:1-9. doi:10.1155/2021/5559383

BibTeX
@article{Xie2021,
  author = {Xie, Dan and Feng, Ling and Huang, Hongyan and Zhao, Quanzhen and Ning, Pingping and Shen, Qiuyan and Lu, Haitao and Xu, Fang and Xu, Yanming},
  title = {Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson’s Disease: A Meta-Analysis},
  journal = {Behavioural Neurology},
  year = {2021},
  volume = {2021},
  pages = {1--9},
  doi = {10.1155/2021/5559383}
}
Kostenlos starten →